Chapter20 The Lymphatic and Immune System
Acquired immune deficiency syndrome, or AIDS, turned out to be a new disease caused by the previously unknown human immunodeficiency virus (HIV). Although nearly 100 percent fatal in those with active HIV infections in the early years, the development of anti-HIV drugs has transformed HIV infection into a chronic, manageable disease and not the certain death sentence it once was. One positive outcome resulting from the emergence of HIV disease was that the public’s attention became focused as never before on the importance of having a functional and healthy immune system.
20.1 Anatomy of the Lymphatic and Immune Systems
The immune system is the complex collection of cells and organs that destroys or neutralizes pathogens that would otherwise cause disease or death. The lymphatic system, for most people, is associated with the immune system to such a degree that the two systems are virtually indistinguishable. The lymphatic system is the system of vessels, cells, and organs that carries excess fluids to the bloodstream and filters pathogens from the blood. The swelling of lymph nodes during an infection and the transport of lymphocytes via the lymphatic vessels are but two examples of the many connections between these critical organ systems.
Functions of the Lymphatic System
A major function of the lymphatic system is to drain body fluids and return them to the bloodstream. Blood pressure causes leakage of fluid from the capillaries, resulting in the accumulation of fluid in the interstitial space—that is, spaces between individual cells in the tissues. In humans, 20 L of plasma are released into the interstitial space of the tissues each day due to capillary filtration. Once this filtrate is out of the bloodstream and in the tissue spaces, it is referred to as interstitial fluid. Of this, 17 L are reabsorbed directly by the blood vessels. But what happens to the remaining 3 L? This is where the lymphatic system comes into play. It drains the excess fluid and empties it back into the bloodstream via a series of vessels, trunks, and ducts. Lymph is the term used to describe interstitial fluid once it has entered the lymphatic system. When the lymphatic system is damaged in some way, such as by being blocked by cancer cells or destroyed by injury, protein-rich interstitial fluid accumulates (sometimes “backs up” from the lymph vessels) in the tissue spaces. This inappropriate accumulation of fluid, referred to as lymphedema, may lead to serious medical consequences.
As the vertebrate immune system evolved, the network of lymphatic vessels became a convenient avenue for transporting the cells of the immune system. Additionally, the transport of dietary lipids and fat-soluble vitamins absorbed in the gut uses this system.
Cells of the immune system not only use lymphatic vessels to make their way from interstitial spaces back into the circulation, but they also use lymph nodes as major staging areas for the development of critical immune responses. A lymph node is one of the small, bean-shaped organs located throughout the lymphatic system.
Structure of the Lymphatic System
The lymphatic vessels begin as blind ending capillaries (closed at one end), which feed into larger and larger lymphatic vessels and eventually empty into the bloodstream by a series of ducts. Along the way, the lymph travels through the lymph nodes, which are commonly found near the groin, armpits, neck, chest, and abdomen. Humans have about 500–600 lymph nodes throughout the body (Figure 20.1).
A major distinction between the lymphatic and cardiovascular systems in humans is that lymph is not actively pumped by the heart but forced through the vessels by the movements of the body, the contraction of skeletal muscles during body movements, and breathing. One-way valves (semilunar valves) in lymphatic vessels keep the lymph moving toward the heart. Lymph flows from the lymphatic capillaries, through lymphatic vessels, and then is dumped into the circulatory system via the lymphatic ducts located at the junction of the jugular and subclavian veins in the neck.
Lymphatic Capillaries
Lymphatic capillaries, also called the terminal lymphatics, are vessels where interstitial fluid enters the lymphatic system to become lymph fluid. Located in almost every tissue in the body, these vessels are interlaced among the arterioles and venules of the circulatory system in the soft connective tissues of the body (Figure 20.2). Exceptions are the central nervous system, bone marrow, bones, teeth, and the cornea of the eye, which do not contain lymph vessels.
Figure 20.1 Anatomy of the Lymphatic System. Lymphatic vessels in the arms and legs convey lymph to the larger lymphatic vessels in the torso.
Lymphatic capillaries are formed by a one-cell-thick layer of endothelial cells and represent the open end of the system, allowing interstitial fluid to flow into them via overlapping cells (see Figure 20.2). When interstitial pressure is low, the endothelial flaps close to prevent “backflow.” As interstitial pressure increases, the spaces between the cells open up, allowing the fluid to enter. Entry of fluid into lymphatic capillaries is also enabled by the collagen filaments that anchor the capillaries to surrounding structures. As interstitial pressure increases, the filaments pull on the endothelial cell flaps, opening them up even further to allow easy entry of fluid.
In the small intestine, lymphatic capillaries called lacteals are critical for the transport of dietary lipids and lipid-soluble vitamins to the bloodstream. In the small intestine, dietary triglycerides combine with other lipids and proteins and enter the lacteals to form a milky fluid called chyle. The chyle then travels through the lymphatic system, eventually entering the bloodstream.
Figure 20.2 Lymphatic Capillaries. Lymphatic capillaries are interlaced with the arterioles and venules of the cardiovascular system. Collagen fibres anchor a lymphatic capillary in the tissue (inset). Interstitial fluid slips through spaces between the overlapping endothelial cells that compose the lymphatic capillary.
Larger Lymphatic Vessels, Trunks, and Ducts
The lymphatic capillaries empty into larger lymphatic vessels, which are similar to veins in terms of their three-tunic structure and the presence of valves. These one-way valves are located fairly close to one another, and each one causes a bulge in the lymphatic vessel, giving the vessels a beaded appearance (see Figure 20.2).
The superficial and deep lymphatics eventually merge to form larger lymphatic vessels known as lymphatic trunks. On the right side of the body, the right sides of the head, thorax, and right upper limb drain lymph fluid into the right subclavian vein via the right lymphatic duct (Figure 20.3). The remaining portions of the left side of the body drain into the larger thoracic duct, which drains into the left subclavian vein. The thoracic duct itself begins just beneath the diaphragm in the cisterna chyli, a sac-like chamber that receives lymph from the lower abdomen, pelvis, and lower limbs by way of the left and right lumbar trunks and the intestinal trunk.
The overall drainage system of the body is asymmetrical (see Figure 20.3). The right lymphatic duct receives lymph from only the upper right side of the body. The lymph from the rest of the body enters the bloodstream through the thoracicduct via all the remaining lymphatic trunks. In general, the lymphatic vessels of the subcutaneous tissues of the skin—that is, the superficial lymphatics—follow the same routes as veins, whereas the deep lymphatic vessels of the viscera generally follow the paths of arteries.
Figure 20.3 Major Trunks and Ducts of the Lymphatic System. The thoracic duct drains a much larger portion of the body than does the right lymphatic duct.
The Organization of Immune Function
The immune system is a collection of barriers, cells, and soluble proteins that interact and communicate with each other in extraordinarily complex ways. The modern model of immune function is organized into three phases based on the timing of their effects. The three temporal phases consist of the following:
- • Barrier defences such as the skin and mucous membranes, which act instantaneously to prevent pathogenic invasion of the body tissues
- • The rapid but nonspecific innate immune response, which consists of a variety of specialized cells and soluble factors
- • The slower but more specific and effective adaptive immune response, which involves many cell types and soluble factors but is primarily controlled by white blood cells (leukocytes) known as lymphocytes, which help control immune responses
The cells of the blood, including all those involved in the immune response, arise in the bone marrow via various differentiation pathways from hematopoietic stem cells (Figure 20.4). In contrast with embryonic stem cells, hematopoietic stem cells are present throughout adulthood and allow for the continuous differentiation of blood cells to replace those lost to age or function. These cells can be divided into three classes based on function:
- • Phagocytic cells, which ingest pathogens to destroy them
- • Lymphocytes, which specifically coordinate the activities of adaptive immunity
- • Cells containing cytoplasmic granules, which help mediate immune responses against parasites and intracellular pathogens such as viruses
Figure 20.4 Hematopoietic System of the Bone Marrow. All the cells of the immune response as well as of the blood arise by differentiation from hematopoietic stem cells. Platelets are cell fragments involved in the clotting of blood.
Lymphocytes: B Cells, T Cells, Plasma Cells, and Natural Killer Cells
As stated in the previous section, lymphocytes are the primary cells of adaptive immune responses (Table 20.1). The two basic types of lymphocytes, B cells and T cells, are identical morphologically, with a large central nucleus surrounded by a thin layer of cytoplasm. They are distinguished from each other by their surface protein markers as well as by the molecules they secrete. While B cells mature in red bone marrow and T cells mature in the thymus, they both initially develop from bone marrow. T cells migrate from bone marrow to the thymus gland, where they further mature. B cells and T cells are found in many parts of the body, circulating in the bloodstream and lymph and residing in secondary lymphoid organs, including the spleen and lymph nodes, which will be described later in this section. The human body contains approximately 1,012 lymphocytes.
Type of lymphocyte | Primary function |
|---|---|
B lymphocyte | Generates diverse antibodies |
T lymphocyte | Secretes chemical messengers |
Plasma cell | Secretes antibodies |
NK cell | Destroys virally infected cells |
B Cells
B cells are immune cells that function primarily by producing antibodies. An antibody is any of the group of proteins that binds specifically to pathogen-associated molecules known as antigens. An antigen is a chemical structure on the surface of a pathogen that binds to T or B lymphocyte antigen receptors. Once activated by binding to an antigen, B cells differentiate into cells that secrete a soluble form of their surface antibodies. These activated B cells are known as plasma cells.
T Cells
The T cell, on the other hand, does not secrete antibodies but performs a variety of functions in the adaptive immune response. Different T cell types have the ability to either secrete soluble factors that communicate with other cells of the adaptive immune response or destroy cells infected with intracellular pathogens. The roles of T and B lymphocytes in the adaptive immune response will be discussed further in this chapter.
Plasma Cells
Another type of lymphocyte of importance is the plasma cell. A plasma cell is a B cell that has differentiated in response to antigen binding and has thereby gained the ability to secrete soluble antibodies. These cells differ in morphology from standard B and T cells in that they contain a large amount of cytoplasm packed with the protein-synthesizing machinery known as rough endoplasmic reticulum.
Natural Killer Cells
A fourth important lymphocyte is the natural killer cell, a participant in the innate immune response. A natural killer (NK) cell is a circulating blood cell that contains cytotoxic (cell-killing) granules in its extensive cytoplasm. It shares this mechanism with the cytotoxic T cells (Tc) of the adaptive immune response. NK cells are among the body’s first lines of defence against viruses and certain types of cancer.
Primary Lymphoid Organs and Lymphocyte Development
Knowledge of B and T cell differentiation and development is fundamental to understanding the adaptive immune response. It is through this process that the body (ideally) learns to destroy only pathogens and leaves the body’s own cells relatively intact. The primary lymphoid organs are the bone marrow and thymus gland. The lymphoid organs are where lymphocytes mature, proliferate, and are selected, which enables them to attack pathogens without harming the cells of the body.
Bone Marrow
In the embryo, blood cells are made in the yolk sac. As development proceeds, this function is taken over by the spleen, lymph nodes, and liver. Later, the bone marrow takes over most hematopoietic functions, although the final stages of the differentiation of some cells may take place in other organs. The red bone marrow is a loose collection of cells where hematopoiesis occurs, and the yellow bone marrow is a site of energy storage, which consists largely of fat cells (Figure 20.5).
Figure 20.5 Bone Marrow. Red bone marrow fills the head of the femur, and a spot of yellow bone marrow is visible in the centre. The white reference bar is 1 cm.
The B cell undergoes nearly all of its development in the red bone marrow, whereas the immature T cell, called a thymocyte, leaves the bone marrow and matures largely in the thymus gland.
Thymus
The thymus, also called the thymus gland, is a bilobed organ found in the space between the sternum and the aorta of the heart (Figure 20.6). Connective tissue holds the lobes closely together but also separates them and forms a capsule.
The connective tissue capsule further divides the thymus into lobules via extensions called trabeculae. The outer region of the organ is known as the cortex and contains large numbers of thymocytes with some epithelial cells, macrophages, and dendritic cells (two types of phagocytic cells that are derived from monocytes). The cortex is densely packed, so it stains more intensely than the rest of the thymus (see Figure 20.6). The medulla, where thymocytes migrate before leaving the thymus, contains a less dense collection of thymocytes, epithelial cells, and dendritic cells.
Figure 20.6 Location, Structure, and Histology of the Thymus. The thymus lies above the heart. The trabeculae and lobules, including the darkly staining cortex and the lighter-staining medulla of each lobule, are clearly visible in the light micrograph of the thymus of a newborn. LM × 100. (Micrograph provided by the Regents of the University of Michigan Medical School © 2012)
Secondary Lymphoid Organs and Their Roles in Active Immune Responses
Lymphocytes develop and mature in the primary lymphoid organs, but they mount immune responses from the secondary lymphoid organs. A naive lymphocyte is one that has left the primary organ and entered a secondary lymphoid organ. Naive lymphocytes are fully functional immunologically but have yet to encounter an antigen to respond to. In addition to circulating in the blood and lymph, lymphocytes concentrate in secondary lymphoid organs, which include the lymph nodes, spleen, and lymphoid nodules. All of these tissues have many features in common, including the following:
- • The presence of lymphoid follicles, the sites of the formation of lymphocytes, with specific B cell–rich and T cell–rich areas
- • An internal structure of reticular fibres with associated fixed macrophages
- • Germinal centres, which are the sites of rapidly dividing and differentiating B lymphocytes
- • Specialized postcapillary vessels known as high endothelial venules; the cells lining these venules are thicker and more columnar than normal endothelial cells, which allow cells from the blood to directly enter these tissues
Lymph Nodes
Lymph nodes function to remove debris and pathogens from the lymph and are thus sometimes referred to as the “filters of the lymph” (Figure 20.7). Any bacteria that infect the interstitial fluid are taken up by the lymphatic capillaries and transported to a regional lymph node. Dendritic cells and macrophages within this organ internalize and kill many of the pathogens that pass through, thereby removing them from the body. The lymph node is also the site of adaptive immune responses mediated by T cells, B cells, and accessory cells of the adaptive immune system. Like the thymus, the bean-shaped lymph nodes are surrounded by a tough capsule of connective tissue and are separated into compartments by trabeculae, the extensions of the capsule. In addition to the structure provided by the capsule and trabeculae, the structural support of the lymph node is provided by a series of reticular fibres laid down by fibroblasts.
Figure 20.7 Structure and Histology of a Lymph Node. Lymph nodes are masses of lymphatic tissue located along the larger lymph vessels. The micrograph of the lymph nodes shows a germinal centre, which consists of rapidly dividing B cells surrounded by a layer of T cells and other accessory cells. LM × 128. (Micrograph provided by the Regents of the University of Michigan Medical School © 2012)
The major routes into the lymph node are via afferent lymphatic vessels (see Figure 20.7). Cells and lymph fluid that leave the lymph node may do so by another set of vessels known as the efferent lymphatic vessels. Lymph from afferent lymphatic vessels enters the lymph node via the subcapsular sinus, which is occupied by dendritic cells, macrophages, and reticular fibres. Within the cortex of the lymph node are lymphoid follicles, which consist of germinal centres of rapidly dividing B cells surrounded by a layer of T cells and other accessory cells. As the lymph continues to flow through the node, it enters the medulla, which consists of medullary cords of B cells and plasma cells, and the medullary sinuses, where the lymph collects before leaving the node via the efferent lymphatic vessels.
Spleen
In addition to the lymph nodes, the spleen is a major secondary lymphoid organ (Figure 20.8). It is about 12 cm long and is attached to the lateral border of the stomach via the gastrosplenic ligament. The spleen is a fragile organ without a strong capsule and is dark red due to its extensive vascularization. The spleen is sometimes called the “filter of the blood” because of its extensive vascularization and the presence of macrophages and dendritic cells that remove microbes and other materials from the blood, including dying red blood cells. The spleen also functions as the location of immune responses to blood-borne pathogens.
The spleen is also divided by trabeculae of connective tissue, and within each splenic nodule is an area of red pulp, consisting of mostly red blood cells, and white pulp, which resembles the lymphoid follicles of the lymph nodes.
Upon entering the spleen, the splenic artery splits into several arterioles (surrounded by white pulp) and eventually into sinusoids. Blood from the capillaries subsequently collects in the venous sinuses and leaves via the splenic vein. The red pulp consists of reticular fibres with fixed macrophages attached, free macrophages, and all of the other cells typical of the blood, including some lymphocytes. The white pulp surrounds a central arteriole and consists of germinal centres of dividing B cells surrounded by T cells and accessory cells, including macrophages and dendritic cells. Thus, the red pulp primarily functions as a filtration system of the blood, using cells of the relatively nonspecific immune response, and white pulp is where adaptive T and B cell responses are mounted.
Figure 20.8 Spleen. (a) The spleen is attached to the stomach. (b) A micrograph of spleen tissue shows the germinal centre. The marginal zone is the region between the red pulp and white pulp, which sequesters particulate antigens from the circulation and presents these antigens to lymphocytes in the white pulp. EM × 660. (Micrograph provided by the Regents of the University of Michigan Medical School © 2012)
Lymphoid Nodules
The other lymphoid tissues, the lymphoid nodules, have a simpler architecture than the spleen and lymph nodes in that they consist of a dense cluster of lymphocytes without a surrounding fibrous capsule. These nodules are located in the respiratory and digestive tracts, areas routinely exposed to environmental pathogens.
Tonsils (specifically named the palatine, pharyngeal, and lingual tonsils) are lymphoid nodules located along the inner surface of the pharynx and are important in developing immunity to oral pathogens (Figure 20.9). The tonsil located at the back of the throat, the pharyngeal tonsil, is sometimes referred to as the adenoid when swollen. Such swelling is an indication of an active immune response to infection. Histologically, tonsils do not contain a complete capsule, and the epithelial layer invaginates deeply into the interior of the tonsil to form tonsillar crypts. These structures, which accumulate all sorts of materials taken into the body through eating and breathing, actually “encourage” pathogens to penetrate deep into the tonsillar tissues, where they are acted upon by numerous lymphoid follicles and eliminated. This seems to be the major function of tonsils—to help children’s bodies recognize, destroy, and develop immunity to common environmental pathogens so that they will be protected in their later lives. Tonsils are often removed in those children who have recurring throat infections, especially those involving the palatine tonsils on either side of the throat, whose swelling may interfere with their breathing and/or swallowing.
Figure 20.9 Locations and Histology of the Tonsils. (a) The pharyngeal tonsil is located on the roof of the posterior superior wall of the nasopharynx. The palatine tonsils lay on each side of the pharynx. (b) A micrograph shows the palatine tonsil tissue. LM × 40. (Micrograph provided by the Regents of the University of Michigan Medical School © 2012)
Mucosa-associated lymphoid tissue (MALT) consists of an aggregate of lymphoid follicles directly associated with the mucous membrane epithelia. MALT makes up dome-shaped structures found underlying the mucosa of the gastrointestinal tract, breast tissue, lungs, and eyes. Peyer’s patches, a type of MALT in the small intestine, are especially important for immune responses against ingested substances (Figure 20.10). Peyer’s patches contain specialized endothelial cells called M (or microfold) cells that sample material from the intestinal lumen and transport it to nearby follicles so that adaptive immune responses to potential pathogens can be mounted. A similar process occurs involving MALT in the mucosa and submucosa of the appendix. A blockage of the lumen triggers these cells to elicit an inflammatory response that can lead to appendicitis.
Bronchus-associated lymphoid tissue (BALT) consists of lymphoid follicular structures with an overlying epithelial layer found along the bifurcations of the bronchi and between bronchi and arteries. They also have the typically less-organized structure of other lymphoid nodules. These tissues, in addition to the tonsils, are effective against inhaled pathogens.
Figure 20.10 Mucosa-Associated Lymphoid Tissue (MALT) Nodule. LM × 40. (Micrograph provided by the Regents of the University of Michigan Medical School © 2012)
20.2 Barrier Defences and the Innate Immune Response
The immune system can be divided into two overlapping mechanisms to destroy pathogens: the innate immune response, which is relatively rapid but nonspecific and thus not always effective, and the adaptive immune response, which is slower in its development during an initial infection with a pathogen but is highly specific and effective at attacking a wide variety of pathogens (Figure 20.11).
Any discussion of the innate immune response usually begins with the physical barriers that prevent pathogens from entering the body, destroy them after they enter, or flush them out before they can establish themselves in the hospitable environment of the body’s soft tissues. Barrier defences are part of the body’s most basic defence mechanisms. The barrier defences are not a response to infections, but they are continuously working to protect against a broad range of pathogens.
The different modes of barrier defences are associated with the external surfaces of the body, where pathogens may try to enter (Table 20.2). The primary barrier to the entrance of microorganisms into the body is the skin. Not only is the skin covered with a layer of dead, keratinized epithelium that is too dry for bacteria to grow in, but as these cells are continuously sloughed off from the skin, they carry bacteria and other pathogens with them.
Figure 20.11 Cooperation Between Innate and Adaptive Immune Responses. The innate immune system enhances adaptive immune responses so they can be more effective.
Additionally, sweat and other skin secretions may lower pH, contain toxic lipids, and physically wash microbes away.
Site | Specific defence | Protective aspect |
|---|---|---|
Skin | Epidermal surface | Keratinized cells of surface, Langerhans cells |
Skin (sweat/secretions) | Sweat glands, sebaceous glands | Low pH, washing action |
Oral cavity | Salivary glands | Lysozyme |
Stomach | Gastrointestinal tract | Low pH |
Mucosal surfaces | Mucosal epithelium | Nonkeratinized epithelial cells |
Normal flora (nonpathogenic bacteria) | Mucosal tissues | Prevent pathogens from growing on mucosal surfaces |
Another barrier is the saliva in the mouth, which is rich in lysozyme—an enzyme that destroys bacteria by digesting their cell walls. The acidic environment of the stomach, which is fatal to many pathogens, is also a barrier.
Additionally, the mucus layer of the gastrointestinal tract, respiratory tract, reproductive tract, eyes, ears, and nose traps both microbes and debris and facilitates their removal. In the case of the upper respiratory tract, ciliated epithelial cells move potentially contaminated mucus upward to the mouth, where it is then swallowed into the digestive tract, ending up in the harsh acidic environment of the stomach. Considering how often you breathe compared to how often you eat or perform other activities that expose you to pathogens, it is not surprising that multiple barrier mechanisms have evolved to work in concert to protect this vital area.
Cells of the Innate Immune Response
A phagocyte is a cell that is able to surround and engulf a particle or cell, a process called phagocytosis. Phagocytes of the immune system engulf particles or cells to remove debris, such as dead or damaged cells, or to destroy pathogens like bacteria. Phagocytes are the body’s fast-acting, first line of immunological defence against organisms that have breached barrier defences and have entered the vulnerable tissues of the body.
Phagocytes: Macrophages and Neutrophils
Many of the cells of the immune system have a phagocytic ability, at least at some point during their life cycles. Phagocytosis is an important and effective mechanism of destroying pathogens during innate immune responses. The phagocyte takes the organism inside itself as a phagosome, which subsequently fuses with a lysosome and its digestive enzymes, effectively killing many pathogens. On the other hand, some bacteria, including Mycobacterium tuberculosis, the cause of tuberculosis, may be resistant to these enzymes and are therefore much more difficult to clear from the body. Macrophages, neutrophils, and dendritic cells are the major phagocytes of the immune system.
A macrophage is an irregularly shaped phagocyte that is amoeboid in nature and is the most versatile of the phagocytes in the body. Macrophages move through tissues and squeeze through capillary walls using pseudopodia. They not only participate in innate immune responses but have also evolved to cooperate with lymphocytes as part of the adaptive immune response. Macrophages exist in many tissues of the body, either freely roaming through connective tissues or fixed to reticular fibres within specific tissues such as lymph nodes. When pathogens breach the body’s barrier defences, macrophages are the first line of defence (Table 20.3). They are called different names, depending on the tissue: Kupffer cells in the liver, histiocytes in connective tissue, and alveolar macrophages in the lungs.
A neutrophil is a phagocytic cell that is attracted via chemotaxis from the bloodstream to infected tissues. These spherical cells are granulocytes. A granulocyte contains cytoplasmic granules, which in turn contain a variety of vasoactive mediators such as histamine. In contrast, macrophages are agranulocytes. An agranulocyte has few or no cytoplasmic granules. Whereas macrophages act like sentries, always on guard against infection, neutrophils can be thought of as military reinforcements that are called into a battle to hasten the destruction of the enemy. Although usually thought of as the primary pathogen-killing cell of the inflammatory process of the innate immune response, new research has suggested that neutrophils play a role in the adaptive immune response as well, just as macrophages do.
Cell | Cell type | Primary location | Function in the innate immune response |
|---|---|---|---|
Macrophage | Agranulocyte | Body cavities/organs | Phagocytosis |
Neutrophil | Granulocyte | Blood | Phagocytosis |
Monocyte | Agranulocyte | Blood | Precursor of macrophage/dendritic cell |
A monocyte is a circulating precursor cell that differentiates into either a macrophage or a dendritic cell, which can be rapidly attracted to areas of infection by signal molecules of inflammation.
Natural Killer Cells
NK cells are a type of lymphocyte that have the ability to induce apoptosis—that is, programmed cell death—in cells infected with intracellular pathogens such as obligate intracellular bacteria and viruses. NK cells recognize these cells by mechanisms that are still not well understood but that presumably involve their surface receptors. NK cells can induce apoptosis, in which a cascade of events inside the cell causes its own death by either of two mechanisms:
- 1. NK cells are able to respond to chemical signals and express the fas ligand. The fas ligand is a surface molecule that binds to the fas molecule on the surface of the infected cell, sending it apoptotic signals, thus killing the cell and the pathogen within it; or
- 2. The granules of the NK cells release perforins and granzymes. A perforin is a protein that forms pores in the membranes of infected cells. A granzyme is a protein-digesting enzyme that enters the cell via the perforin pores and triggers apoptosis intracellularly.
Both mechanisms are especially effective against virally infected cells. If apoptosis is induced before the virus has the ability to synthesize and assemble all its components, no infectious virus will be released from the cell, thus preventing further infection.
Recognition of Pathogens
Cells of the innate immune response, the phagocytic cells, and the cytotoxic NK cells recognize patterns of pathogen-specific molecules, such as bacterial cell wall components or bacterial flagellar proteins, using pattern recognition receptors. A pattern recognition receptor (PRR) is a membrane-bound receptor that recognizes characteristic features of a pathogen and molecules released by stressed or damaged cells.
These receptors, which are thought to have evolved prior to the adaptive immune response, are present on the cell surface whether they are needed or not. Their variety, however, is limited by two factors. First, the fact that each receptor type must be encoded by a specific gene requires the cell to allocate most or all of its DNA to make receptors able to recognize all pathogens. Second, the variety of receptors is limited by the finite surface area of the cell membrane. Thus, the innate immune system must “get by” using only a limited number of receptors that are active against as wide a variety of pathogens as possible. This strategy is in stark contrast to the approach used by the adaptive immune system, which uses large numbers of different receptors, each highly specific to a particular pathogen.
Should the cells of the innate immune system come into contact with a species of pathogen they recognize, the cell will bind to the pathogen and initiate phagocytosis (or cellular apoptosis in the case of an intracellular pathogen) in an effort to destroy the offending microbe. Receptors vary somewhat according to cell type, but they usually include receptors for bacterial components and for complement, discussed below.
Soluble Mediators of the Innate Immune Response
The previous discussions have alluded to chemical signals that can induce cells to change various physiological characteristics, such as the expression of a particular receptor. These soluble factors are secreted during innate or early induced responses and later during adaptive immune responses.
Cytokines and Chemokines
A cytokine is a signalling molecule that allows cells to communicate with each other over short distances. Cytokines are secreted into the intercellular space, and the action of the cytokine induces the receiving cell to change its physiology. A chemokine is a soluble chemical mediator similar to cytokines except that its function is to attract cells (chemotaxis) from longer distances.
Early Induced Proteins
Early induced proteins are those that are not constitutively present in the body but are made as they are needed early during the innate immune response. Interferons are an example of early induced proteins. Cells infected with viruses secrete interferons that travel to adjacent cells and induce them to make antiviral proteins. Thus, even though the initial cell is sacrificed, the surrounding cells are protected. Other early induced proteins specific for bacterial cell wall components are mannose-binding protein and C-reactive protein, made in the liver, which bind specifically to polysaccharide components of the bacterial cell wall. Phagocytes such as macrophages have receptors for these proteins, and they are thus able to recognize them as they are bound to the bacteria. This brings the phagocyte and bacterium into close proximity and enhances the phagocytosis of the bacterium by the process known as opsonization. Opsonization is the tagging of a pathogen for phagocytosis by the binding of an antibody or an antimicrobial protein.
Complement System
The complement system is a series of proteins constitutively found in the blood plasma. As such, these proteins are not considered part of the early induced immune response, even though they share features with some of the antibacterial proteins of this class. Made in the liver, they have a variety of functions in the innate immune response, using what is known as the “alternate pathway” of complement activation. Additionally, the complement system functions in the adaptive immune response as well in what is called the classical pathway. The complement system consists of several proteins that enzymatically alter and fragment later proteins in a series, which is why it is termed cascade. Once activated, the series of reactions is irreversible and releases fragments that have the following actions:
- • Bind to the cell membrane of the pathogen that activates it, labelling it for phagocytosis (opsonization)
- • Diffuse away from the pathogen and act as chemotactic agents to attract phagocytic cells to the site of inflammation
- • Form damaging pores in the plasma membrane of the pathogen.
Inflammatory Response
The hallmark of the innate immune response is inflammation. Inflammation is something everyone has experienced. Stub a toe, cut a finger, or do any activity that causes tissue damage and inflammation will result, with its four characteristics: heat, redness, pain, and swelling (“loss of function” is sometimes mentioned as a fifth characteristic). It is important to note that inflammation does not have to be initiated by an infection but can also be caused by tissue injuries. The release of damaged cellular contents into the site of injury is enough to stimulate the response, even in the absence of breaks in physical barriers that would allow pathogens to enter (by hitting your thumb with a hammer, for example). The inflammatory reaction brings phagocytic cells to the damaged area to clear cellular debris and to set the stage for wound repair (Figure 20.12).
This reaction also brings in the cells of the innate immune system, allowing them to get rid of the sources of a possible infection. Inflammation is part of a very basic form of immune response. The process not only brings fluid and cells into the site to destroy the pathogen and remove it and debris from the site but also helps isolate the site, limiting the spread of the pathogen. Acute inflammation is a short-term inflammatory response to an insult to the body. If the cause of the inflammation is not resolved, however, it can lead to chronic inflammation, which is associated with major tissue destruction and fibrosis. Chronic inflammation is ongoing inflammation. It can be caused by foreign bodies, persistent pathogens, and autoimmune diseases such as rheumatoid arthritis.
Figure 20.12 The Inflammatory Reaction.
There are four important parts to the inflammatory response:
- • Tissue Injury. The released contents of injured cells stimulate the release of mast cell granules and their potent inflammatory mediators, such as histamine, leukotrienes, and prostaglandins. Histamine increases the diameter of local blood vessels (vasodilation), causing an increase in blood flow. Histamine also increases the permeability of local capillaries, causing plasma to leak out and form interstitial fluid. This causes the swelling associated with inflammation.
Additionally, injured cells, phagocytes, and basophils are sources of inflammatory mediators, including prostaglandins and leukotrienes. Leukotrienes attract neutrophils from the blood by chemotaxis and increase vascular permeability. Prostaglandins cause vasodilation by relaxing vascular smooth muscle and are a major cause of the pain associated with inflammation. Nonsteroidal anti-inflammatory drugs such as aspirin and ibuprofen relieve pain by inhibiting prostaglandin production.
- • Vasodilation. Many inflammatory mediators such as histamine are vasodilators that increase the diameters of local capillaries. This causes increased blood flow and is responsible for the heat and redness of inflamed tissue. It allows greater access of the blood to the site of inflammation.
- • Increased Vascular Permeability. At the same time, inflammatory mediators increase the permeability of the local vasculature, causing leakage of fluid into the interstitial space, resulting in the swelling, or edema, associated with inflammation.
- • Recruitment of Phagocytes. Leukotrienes are particularly good at attracting neutrophils from the blood to the site of infection by chemotaxis. Following an early neutrophil infiltrate stimulated by macrophage cytokines, more macrophages are recruited to clean up the debris left over at the site. When local infections are severe, neutrophils are attracted to the sites of infections in large numbers, and as they phagocytose the pathogens and subsequently die, their accumulated cellular remains are visible as pus at the infection site.
Overall, inflammation is valuable for many reasons. Not only are the pathogens killed and debris removed, but the increase in vascular permeability encourages the entry of clotting factors, the first step toward wound repair.
Inflammation also facilitates the transport of antigen to lymph nodes by dendritic cells for the development of the adaptive immune response.
20.3 The Adaptive Immune Response: T Lymphocytes and Their Functional Types
Innate immune responses (and early induced responses) are in many cases ineffective at completely controlling pathogen growth. However, they slow pathogen growth and allow time for the adaptive immune response to strengthen and either control or eliminate the pathogen. The innate immune system also sends signals to the cells of the adaptive immune system, guiding them in how to attack the pathogen. Thus, these are the two important arms of the immune response.
The Benefits of the Adaptive Immune Response
The specificity of the adaptive immune response—its ability to specifically recognize and make a response against a wide variety of pathogens—is its great strength. Antigens, the small chemical groups often associated with pathogens, are recognized by receptors on the surface of B and T lymphocytes. The adaptive immune response to these antigens is so versatile that it can respond to nearly any pathogen. This increase in specificity comes because the adaptive immune response has a unique way to develop as many as 1011, or 100 trillion, different receptors to recognize nearly every conceivable pathogen.
Primary Disease and Immunological Memory
The immune system’s first exposure to a pathogen is called a primary adaptive response. Symptoms of a first infection, called primary disease, are always relatively severe because it takes time for an initial adaptive immune response to a pathogen to become effective.
Upon reexposure to the same pathogen, a secondary adaptive immune response is generated, which is stronger and faster than the primary response. The secondary adaptive response often eliminates a pathogen before it can cause significant tissue damage or any symptoms. Without symptoms, there is no disease, and the individual is not even aware of the infection. This secondary response is the basis of immunological memory, which protects us from getting diseases repeatedly from the same pathogen. By this mechanism, an individual’s exposure to pathogens early in life spares the person from these diseases later in life.
Self-Recognition
A third important feature of the adaptive immune response is its ability to distinguish between self-antigens, those that are normally present in the body, and foreign antigens, those that might be on a potential pathogen. As T and B cells mature, there are mechanisms in place that prevent them from recognizing self-antigens, preventing a damaging immune response against the body. These mechanisms are not 100 percent effective, however, and their breakdown leads to autoimmune diseases, which will be discussed later in this chapter.
T Cell–Mediated Immune Responses
The primary cells that control the adaptive immune response are the lymphocytes, the T and B cells. T cells are particularly important, as they not only control a multitude of immune responses directly but also control B cell immune responses in many cases as well. Thus, many of the decisions about how to attack a pathogen are made at the T cell level, and knowledge of their functional types is crucial to understanding the functioning and regulation of adaptive immune responses as a whole.
T lymphocytes recognize antigens based on a two-chain protein receptor. The most common and important of these are the alpha-beta T cell receptors (Figure 20.13).
Antigens
Antigens on pathogens are usually large and complex and consist of many antigenic determinants. An antigenic determinant (epitope) is one of the small regions within an antigen to which a receptor can bind, and antigenic determinants are limited by the size of the receptor itself. They usually consist of six or fewer amino acid residues in a protein, or one or two sugar moieties in a carbohydrate antigen. Antigenic determinants on a carbohydrate antigen are usually less diverse than on a protein antigen. Carbohydrate antigens are found on bacterial cell walls and on red blood cells (the ABO blood group antigens). Protein antigens are complex because of the variety of three-dimensional shapes that proteins can assume and are especially important for the immune responses to viruses and worm parasites. It is the interaction of the shape of the antigen and the complementary shape of the amino acids of the antigen-binding site that accounts for the chemical basis of specificity.
Figure 20.13 Alpha-Beta T Cell Receptor. Notice the constant and variable regions of each chain, anchored by the transmembrane region.
Antigen Processing and Presentation
The mechanism that T cells use to recognize antigens is complex. T cells do not recognize free-floating or cell-bound antigens as they appear on the surface of the pathogen. They only recognize antigens on the surface of specialized cells called antigen-presenting cells. Antigens are internalized by these cells. Antigen processing is a mechanism that enzymatically cleaves the antigen into smaller pieces. The antigen fragments are then brought to the cell’s surface and associated with a specialized type of antigen-presenting protein known as a major histocompatibility complex (MHC) molecule. The MHC proteins are encoded by a cluster of genes that encode these antigen-presenting molecules. The association of the antigen fragments with an MHC molecule on the surface of a cell is known as antigen presentation and results in the recognition of antigen by a T cell. This association of antigen and MHC occurs inside the cell, and it is the complex of the two that is brought to the surface. The peptide-binding cleft is a small indentation at the end of the MHC molecule that is farthest away from the cell membrane; it is here that the processed fragment of antigen sits. MHC molecules (which are specifically named class I MHC and class II MHC molecules) are capable of presenting a variety of antigens, depending on the amino acid sequence, in their peptide-binding clefts. It is the combination of the MHC molecule and the fragment of the original peptide or carbohydrate that is actually physically recognized by the T cell receptor (Figure 20.14).
Figure 20.14 Antigen Processing and Presentation.
Professional Antigen-Presenting Cells
Many cell types express class I molecules for the presentation of intracellular antigens. These MHC molecules may then stimulate a cytotoxic T cell immune response, eventually destroying the cell and the pathogen within. This is especially important when it comes to the most common class of intracellular pathogens, the virus. Viruses infect nearly every tissue of the body, so all these tissues must necessarily be able to express class I MHC or no T cell response can be made.
On the other hand, class II MHC molecules are expressed only on the cells of the immune system, specifically cells that affect other arms of the immune response. Thus, these cells are called “professional” antigen-presenting cells to distinguish them from those that bear class I MHC. The three types of professional antigen presenters are macrophages, dendritic cells, and B cells (Table 20.4).
Macrophages stimulate T cells to release cytokines that enhance phagocytosis. Dendritic cells also kill pathogens by phagocytosis (see Figure 20.14), but their major function is to bring antigens to regional draining lymph nodes. The lymph nodes are the locations in which most T cell responses against pathogens of the interstitial tissues are mounted. Macrophages are found in the skin and in the lining of mucosal surfaces, such as the nasopharynx, stomach, lungs, and intestines. B cells may also present antigens to T cells, which are necessary for certain types of antibody responses, to be covered later in this chapter.
MHC | Cell type | Phagocytic? | Function |
|---|---|---|---|
Class I | Many | No | Stimulates cytotoxic T cell immune response |
Class II | Macrophage | Yes | Stimulates phagocytosis and presentation at primary infection site |
Class II | Dendritic | Yes, in tissues | Brings antigens to regional lymph nodes |
Class II | B cell | Yes, internalizes surface Ig and antigen | Stimulates antibody secretion by B cells |
Mechanisms of T Cell–Mediated Immune Responses
Mature T cells become activated by recognizing processed foreign antigen in association with a self-MHC molecule and begin dividing rapidly by mitosis. This proliferation of T cells is called clonal expansion and is necessary to make the immune response strong enough to effectively control a pathogen. How does the body select only those T cells that are needed against a specific pathogen? Again, the specificity of a T cell is based on the amino acid sequence and the three-dimensional shape of the antigen-binding site formed by the variable regions of the two chains of the T cell receptor (Figure 20.15). Clonal selection is the process of antigen binding only to those T cells that have receptors specific to that antigen. Each T cell that is activated has a specific receptor “hardwired” into its DNA, and all of its progeny will have identical DNA and T cell receptors, forming clones of the original T cell.
Clonal Selection and Expansion
The clonal selection theory was proposed by Frank Burnet in the 1950s. However, the term clonal selection is not a complete description of the theory, as clonal expansion goes hand in glove with the selection process. The main tenet of the theory is that a typical individual has a multitude of (1,011) different types of T cell clones based on their receptors. In this use, a clone is a group of lymphocytes that share the same antigen receptor. Each clone is necessarily present in the body in low numbers. Otherwise, the body would not have room for lymphocytes with so many specificities.
Figure 20.15 Clonal Selection and Expansion of T Lymphocytes. Stem cells differentiate into T cells with specific receptors called clones. The clones with receptors specific for antigens on the pathogen are selected for and expanded. The TC cells are cytotoxic T cells, which are described later in this chapter.
Only those clones of lymphocytes whose receptors are activated by the antigen are stimulated to proliferate. Keep in mind that most antigens have multiple antigenic determinants, so a T cell response to a typical antigen involves a polyclonal response. A polyclonal response is the stimulation of multiple T cell clones. Once activated, the selected clones increase in number and make many copies of each cell type, each clone with its unique receptor. By the time this process is complete, the body will have large numbers of specific lymphocytes available to fight the infection (see Figure 20.15).
The Cellular Basis of Immunological Memory
As already discussed, one of the major features of an adaptive immune response is the development of immunological memory.
During a primary adaptive immune response, both memory T cells and effector T cells are generated. Memory T cells are long lived and can even persist for a lifetime. Memory cells are primed to act rapidly. Thus, any subsequent exposure to the pathogen will elicit a very rapid T cell response. This rapid, secondary adaptive response generates large numbers of effector T cells so fast that the pathogen is often overwhelmed before it can cause any symptoms of disease. This is what is meant by immunity to a disease. The same pattern of primary and secondary immune responses occurs in B cells and the antibody response, as will be discussed later in the chapter.
T Cell Types and Their Functions
In T cell development, the mature T cells express specific markers (either the CD4 marker or the CD8 marker, but not both). These markers are cell adhesion molecules that keep the T cell in close contact with the antigen-presenting cell by directly binding to the MHC molecule (to a different part of the molecule than does the antigen). Thus, T cells and antigen-presenting cells are held together in two ways: by any marker attaching to MHC and by the T cell receptor binding to antigen.
Helper T Cells and Their Cytokines
Helper T cells (Th), bearing the CD4 molecule, function by secreting cytokines that act to enhance other immune responses. There are two classes of Th cells, and they act on different components of the immune response. These cells are distinguished not by their surface molecules but by the characteristic set of cytokines they secrete (Table 20.5).
T cell | Main target | Function | Pathogen | Surface marker | MHC | Cytokines or mediators |
|---|---|---|---|---|---|---|
Tc | Infected cells | Cytotoxicity | Intracellular | CD8 | Class I | Perforins, granzymes, and fas ligand |
Th1 | Macrophage | Helper inducer | Extracellular | CD4 | Class II | Interferon-γ and TGF-β |
Th2 | B cell | Helper inducer | Extracellular | CD4 | Class II | IL-4, IL-6, IL-10, and others |
Treg | Th cell | Suppressor | None | CD4, CD25 | ? | TGF-β and IL-10 |
Th1 cells are a type of helper T cell that secretes cytokines that regulate the immunological activity and development of a variety of cells, including macrophages and other types of T cells.
Th2 cells, on the other hand, are cytokine-secreting cells that act on B cells to drive their differentiation into plasma cells that make antibodies. In fact, T cell help is required for antibody responses to most protein antigens, and these are called T cell–dependent antigens.
Cytotoxic T cells
Cytotoxic T cells (Tc) are T cells that kill target cells by inducing apoptosis using the same mechanism as NK cells. They either express fas ligand, which binds to the fas molecule on the target cell, or act by using perforins and granzymes contained in their cytoplasmic granules. As was discussed earlier with NK cells, killing a virally infected cell before the virus can complete its replication cycle results in the production of no infectious particles. As more Tc cells are developed during an immune response, they overwhelm the ability of the virus to cause disease. In addition, each Tc cell can kill more than one target cell, making them especially effective. Tc cells are so important in the antiviral immune response that some speculate that this was the main reason the adaptive immune response evolved in the first place.
Regulatory T Cells
Regulatory T cells (Treg), or suppressor T cells, are the most recently discovered of the types listed here, so less is understood about them. In addition to CD4, they bear the molecules CD25 and FOXP3. Exactly how they function is still under investigation, but it is known that they suppress other T cell immune responses. This is an important feature of the immune response, because if clonal expansion during immune responses were allowed to continue uncontrolled, these responses could lead to autoimmune diseases and other medical issues.
Not only do T cells directly destroy pathogens, but they regulate nearly all other types of the adaptive immune response as well, as evidenced by the functions of the T cell types, their surface markers, the cells they work on, and the types of pathogens they work against (see Table 20.5).
20.4 The Adaptive Immune Response: B Lymphocytes and Antibodies
Antibodies were the first component of the adaptive immune response to be characterized by scientists working on the immune system. It was already known that individuals who survived a bacterial infection were immune to reinfection with the same pathogen. Early microbiologists took serum from an immune patient and mixed it with a fresh culture of the same type of bacteria, then observed the bacteria under a microscope. The bacteria became clumped in a process called agglutination. When a different bacterial species was used, the agglutination did not happen. Thus, there was something in the serum of immune individuals that could specifically bind to and agglutinate bacteria.
Scientists now know that the cause of the agglutination is an antibody molecule, also called an immunoglobulin (Ig). What is an antibody? An antibody protein is essentially a secreted form of a B cell receptor. (In fact, surface immunoglobulin is another name for the B cell receptor.) Not surprisingly, the same genes encode both the secreted antibodies and the surface immunoglobulins. One minor difference in the way these proteins are synthesized distinguishes a naive B cell with antibody on its surface from an antibody-secreting plasma cell with no antibodies on its surface. The antibodies of the plasma cell have the exact same antigen-binding site and specificity as their B cell precursors.
There are five different classes of antibody found in humans: IgM, IgD, IgG, IgA, and IgE. Each of these has specific functions in the immune response, so by learning about them, researchers can learn about the great variety of antibody functions critical to many adaptive immune responses.
B cells do not recognize antigen in the complex fashion of T cells. B cells can recognize native, unprocessed antigen and do not require the participation of MHC molecules and antigen-presenting cells.
B Cell Differentiation and Activation
B cells differentiate in the bone marrow. During the process of maturation, up to 100 trillion different clones of B cells are generated, which is similar to the diversity of antigen receptors seen in T cells.
B cell differentiation and the development of tolerance are not quite as well understood as in T cells. Central tolerance is the destruction or inactivation of B cells that recognize self-antigens in the bone marrow, and its role is critical and well established. In the process of clonal deletion, immature B cells that bind strongly to self-antigens expressed on tissues are signalled to induce their own destruction by apoptosis, removing them from the population. In the process of clonal anergy, however, B cells exposed to soluble antigen in the bone marrow are not physically deleted but become unable to function.
Another mechanism called peripheral tolerance is a direct result of T cell tolerance. In peripheral tolerance, functional, mature B cells leave the bone marrow but have yet to be exposed to self-antigen. Most protein antigens require signals from helper T cells (Th2) to proceed to make antibody. When a B cell binds to a self-antigen but receives no signals from a nearby Th2 cell to produce antibody, the cell is signalled to undergo apoptosis and is destroyed. This is yet another example of the control that T cells have over the adaptive immune response.
After B cells’ activation process by their binding to antigen, they differentiate into plasma cells. Plasma cells often leave the secondary lymphoid organs, where the response is generated, and migrate back to the bone marrow, where the whole differentiation process started. After secreting antibodies for a specific period, they die, as most of their energy is devoted to making antibodies and not to maintaining themselves. Thus, plasma cells are said to be terminally differentiated.
The final B cell of interest is the memory B cell, which results from the clonal expansion of an activated B cell. Memory B cells function in a way similar to memory T cells. They lead to a stronger and faster secondary response when compared to the primary response, as illustrated below.
Antibody Structure
Antibodies are glycoproteins consisting of two types of polypeptide chains with attached carbohydrates. The heavy chain and the light chain are the two polypeptides that form the antibody. The main differences between the classes of antibodies are in the differences between their heavy chains, but as you shall see, the light chains have an important role, forming part of the antigen-binding site on the antibody molecules.
Four-Chain Models of Antibody Structures
All antibody molecules have two identical heavy chains and two identical light chains. (Some antibodies contain multiple units of this four-chain structure.) The Fc region of the antibody is formed by the two heavy chains coming together, usually linked by disulfide bonds (Figure 20.16).
Figure 20.16 Antibody and IgG2 Structures. The typical four-chain structure of a generic antibody (a) and the corresponding three-dimensional structure of the antibody IgG2 (b). (credit b: modification of work by Tim Vickers)
The Fc portion of the antibody is important in that many effector cells of the immune system have Fc receptors. Cells having these receptors can then bind to antibody-coated pathogens, greatly increasing the specificity of the effector cells. At the other end of the molecule are two identical antigen-binding sites.
Five Classes of Antibodies and Their Functions
In general, antibodies have two basic functions. They can act as the B cell antigen receptor, or they can be secreted, circulate, and bind to a pathogen, often labelling it for identification by other forms of the immune response. Of the five antibody classes, notice that only two can function as the antigen receptor for naive B cells: IgM and IgD (Table 20.6). Mature B cells that leave the bone marrow express both IgM and IgD, but both antibodies have the same antigen specificity. Only IgM is secreted, however, and no other nonreceptor function for IgD has been discovered.
IgM consists of five four-chain structures (20 total chains with 10 identical antigen-binding sites) and is thus the largest of the antibody molecules. IgM is usually the first antibody made during a primary response. Its 10 antigen-binding sites and large shape allow it to bind well to many bacterial surfaces. It is excellent at binding complement proteins and activating the complement cascade, consistent with its role in promoting chemotaxis, opsonization, and cell lysis. Thus, it is a very effective antibody against bacteria at early stages of a primary antibody response. As the primary response proceeds, the antibody produced in a B cell can change to IgG, IgA, or IgE by the process known as class switching. Class switching is the change of one antibody class to another. While the class of antibody changes, the specificity and the antigen-binding sites do not. Thus, the antibodies made are still specific to the pathogen that stimulated the initial IgM response.
Property | IgM (pentamer) | IgG (monomer) | Secretory IgA (dimer) | IgE (monomer) | IgD (monomer) |
|---|---|---|---|---|---|
Heavy chains | μ | γ | α | ε | δ |
Number of antigen-binding sites | 10 | 2 | 4 | 2 | 2 |
Molecular weight (daltons) | 900,000 | 150,000 | 385,000 | 200,000 | 180,000 |
Percentage of total antibody in serum | 6 | 80 | 13 | 0.002 | 1 |
Crosses placenta | No | Yes | No | No | No |
Fixes complement | Yes | Yes | No | No | No |
Fc binds to | — | Phagocytes | — | Mast cells and basophils | — |
Function | Main antibody of primary responses; best at fixing complement; the monomer form of IgM serves as the B cell receptor | Main blood antibody of secondary responses, neutralizes toxins, opsonization | Secreted into mucus, tears, saliva, colostrum | Antibody of allergy and antiparasitic activity | B cell receptor |
IgG is a major antibody of late primary responses and the main antibody of secondary responses in the blood. This is because class switching occurs during primary responses. IgG is a monomeric antibody that clears pathogens from the blood and can activate complement proteins (although not as well as IgM), taking advantage of its antibacterial activities. Furthermore, this class of antibody is the one that crosses the placenta to protect the developing fetus from disease and exits the blood to the interstitial fluid to fight extracellular pathogens.
IgA exists in two forms, a four-chain monomer in the blood and an eight-chain structure, or dimer, in exocrine gland secretions of the mucous membranes, including mucus, saliva, and tears. Thus, dimeric IgA is the only antibody to leave the interior of the body to protect body surfaces. IgA is also of importance to newborns, because this antibody is present in the mother’s breast milk (colostrum), which serves to protect the infant from disease.
IgE is usually associated with allergies and anaphylaxis. It is present in the lowest concentration in the blood, because its Fc region binds strongly to an IgE-specific Fc receptor on the surfaces of mast cells. IgE makes mast cell degranulation very specific, such that if a person is allergic to peanuts, there will be peanut-specific IgE bound to their mast cells. In this person, eating peanuts will cause the mast cells to degranulate, sometimes causing severe allergic reactions, including anaphylaxis, a severe, systemic allergic response that can cause death.
Clonal Selection of B Cells
Clonal selection and expansion work in much the same way in B cells as in T cells. Only B cells with appropriate antigen specificity are selected for and expanded (Figure 20.17).
Eventually, the plasma cells secrete antibodies with antigenic specificity identical to those that were on the surfaces of the selected B cells. Notice in the figure that both plasma cells and memory B cells are generated simultaneously.
Primary Versus Secondary B Cell Responses
Primary and secondary responses as they relate to T cells were discussed in section 20.3 The Adaptive Immune Response: T Lymphocytes and Their Functional Types. This section will look at these responses with B cells and antibody production. Because antibodies are easily obtained from blood samples, they are easy to follow and graph (Figure 20.18). As you will see from the figure, the primary response to an antigen (representing a pathogen) is delayed by several days. This is the time it takes for the B cell clones to expand and differentiate into plasma cells. The level of antibody produced is low, but it is sufficient for immune protection. The second time a person encounters the same antigen, there is no time delay, and the amount of antibody made is much higher. Thus, the secondary antibody response overwhelms the pathogens quickly, and in most situations, no symptoms are felt. When a different antigen is used, another primary response is made with its low antibody levels and time delay.
Figure 20.17 Clonal Selection of B Cells. During a primary B cell immune response, both antibody-secreting plasma cells and memory B cells are produced. These memory cells lead to the differentiation of more plasma cells and memory B cells during secondary responses.
Active Versus Passive Immunity
Immunity to pathogens and the ability to control pathogen growth so that damage to the tissues of the body is limited can be acquired by (1) the active development of an immune response in the infected individual or (2) the passive transfer of immune components from an immune individual to a nonimmune one. Both active and passive immunity have examples in the natural world and as part of medicine.
Active immunity is the resistance to pathogens acquired during an adaptive immune response within an individual (Table 20.7). Naturally acquired active immunity, the response to a pathogen, is the focus of this chapter. Artificially acquired active immunity involves the use of vaccines. A vaccine is a killed or weakened pathogen or its components that, when administered to a healthy individual, leads to the development of immunological memory (a weakened primary immune response) without causing much in the way of symptoms. Thus, with the use of vaccines, one can avoid the damage from disease that results from the first exposure to the pathogen yet reap the benefits of protection from immunological memory. The advent of vaccines was one of the major medical advances of the twentieth century and led to the eradication of smallpox and the control of many infectious diseases, including polio, measles, and whooping cough.
Figure 20.18 Primary and Secondary Antibody Responses. Antigen A is given once to generate a primary response and later to generate a secondary response. When a different antigen is given for the first time, a new primary response is made.
Natural | Artificial | |
|---|---|---|
Active | Adaptive immune response | Vaccine response |
Passive | Transplacental antibodies / breastfeeding | Immune globulin injections |
Passive immunity arises from the transfer of antibodies to an individual without requiring them to mount their own active immune response. Naturally acquired passive immunity is seen during fetal development. IgG is transferred from the maternal circulation to the fetus via the placenta, protecting the fetus from infection and protecting the newborn for the first few months of its life. As already stated, a newborn benefits from the IgA antibodies it obtains from milk during breastfeeding. The fetus and newborn thus benefit from the immunological memory based on the pathogens to which the pregnant person has been exposed. In medicine, artificially acquired passive immunity usually involves injections of immunoglobulins, taken from animals previously exposed to a specific pathogen. This treatment is a fast-acting method of temporarily protecting an individual who was possibly exposed to a pathogen. The downside to both types of passive immunity is the lack of the development of immunological memory. Once the antibodies are transferred, they are effective for only a limited time before they degrade.
T Cell–Dependent Versus T Cell–Independent Antigens
As discussed previously, Th2 cells secrete cytokines that drive the production of antibodies in a B cell, responding to complex antigens such as those made by proteins. On the other hand, some antigens are T cell independent. A T cell–independent antigen usually is in the form of repeated carbohydrate moieties found on the cell walls of bacteria. Each antibody on the B cell surface has two binding sites, and the repeated nature of T cell–independent antigen leads to crosslinking of the surface antibodies on the B cell. The crosslinking is enough to activate it in the absence of T cell cytokines.
A T cell–dependent antigen, on the other hand, usually is not repeated to the same degree on the pathogen and thus does not crosslink surface antibody with the same efficiency. To elicit a response to such antigens, the B and T cells must come close together (Figure 20.19). The B cell must receive two signals to become activated. Its surface immunoglobulin must recognize native antigen. Some of this antigen is internalized, processed, and presented to the Th2 cells on a class II MHC molecule. The T cell then binds using its antigen receptor and is activated to secrete cytokines that diffuse to the B cell, finally activating it completely. Thus, the B cell receives signals from both its surface antibody and the T cell via its cytokines and acts as a professional antigen-presenting cell in the process.
Figure 20.19 T and B Cell Binding. To elicit a response to a T cell–dependent antigen, the B and T cells must come close together. To become fully activated, the B cell must receive two signals from the native antigen and the T cell’s cytokines.
Key Terms
- active immunity:
- Immunity developed from an individual’s own immune system.
- acute inflammation:
- Inflammation occurring for a limited time period; rapidly developing.
- adaptive immune response:
- Relatively slow but very specific and effective immune response controlled by lymphocytes.
- afferent lymphatic vessels:
- Vessels that lead into a lymph node.
- antibody:
- Antigen-specific protein secreted by plasma cells; immunoglobulin.
- antigen:
- Molecule recognized by the receptors of B and T lymphocytes.
- antigenic determinant (also epitope):
- One of the chemical groups recognized by a single type of lymphocyte antigen receptor.
- antigen presentation:
- Binding of processed antigen to the protein-binding cleft of a major histocompatibility complex molecule.
- antigen processing:
- Internalization and digestion of antigen in an antigen-presenting cell.
- antigen receptor:
- Two-chain receptor by which lymphocytes recognize antigen.
- barrier defences:
- Antipathogen defences deriving from a barrier that physically prevents pathogens from entering the body to establish an infection.
- B cells:
- Lymphocytes that act by differentiating into an antibody-secreting plasma cell.
- bone marrow:
- Tissue found inside bones; the site of all blood cell differentiation and maturation of B lymphocytes.
- bronchus-associated lymphoid tissue (BALT):
- Lymphoid nodule associated with the respiratory tract.
- central tolerance:
- B cell tolerance induced in immature B cells of the bone marrow.
- chemokine:
- Soluble, long-range, cell-to-cell communication molecule.
- chronic inflammation:
- Inflammation occurring for long periods of time.
- chyle:
- Lipid-rich lymph inside the lymphatic capillaries of the small intestine.
- cisterna chyli:
- Bag-like vessel that forms the beginning of the thoracic duct.
- class I MHC:
- Molecules for the presentation of intracellular antigens; may then stimulate a cytotoxic T cell immune response, eventually destroying the cell and the pathogen within.
- class II MHC:
- Molecules expressed only on the cells of the immune system, specifically cells that affect other arms of the immune response.
- class switching:
- Ability of B cells to change the class of antibody they produce without altering the specificity for antigen.
- clonal anergy:
- Process whereby B cells that react to soluble antigens in bone marrow are made nonfunctional.
- clonal deletion:
- Removal of self-reactive B cells by inducing apoptosis.
- clonal expansion:
- Growth of a clone of selected lymphocytes.
- clonal selection:
- Stimulating growth of lymphocytes that have specific receptors.
- clone:
- Group of lymphocytes sharing the same antigen receptor.
- complement:
- Enzymatic cascade of constitutive blood proteins that have antipathogen effects, including the direct killing of bacteria.
- cytokine:
- Soluble, short-range, cell-to-cell communication molecule.
- cytotoxic T cells (Tc):
- T lymphocytes with the ability to induce apoptosis in target cells.
- dendritic cells:
- Two types of phagocytic cells in the thymus that are derived from monocytes.
- effector T cells:
- Immune cells with a direct, adverse effect on a pathogen.
- efferent lymphatic vessels:
- Vessels that lead out of a lymph node.
- Fc region:
- In an antibody molecule, the site where the two termini of the heavy chains come together; many cells have receptors for this portion of the antibody, adding functionality to these molecules.
- germinal centres:
- Clusters of rapidly proliferating B cells found in secondary lymphoid tissues.
- granzyme:
- Apoptosis-inducing substance contained in granules of NK cells and cytotoxic T cells.
- heavy chain:
- Larger protein chain of an antibody.
- helper T cells (Th):
- T cells that secrete cytokines to enhance other immune responses, involved in activation of both B and T cell lymphocytes.
- histamine:
- Vasoactive mediator in granules of mast cells; the primary cause of allergies and anaphylactic shock.
- IgA:
- Antibody whose dimer is secreted by exocrine glands, is especially effective against digestive and respiratory pathogens, and can pass immunity to an infant through breastfeeding.
- IgD:
- Class of antibody whose only known function is as a receptor on naive B cells; important in B cell activation.
- IgE:
- Antibody that binds to mast cells and causes antigen-specific degranulation during an allergic response.
- Salesforce IgG:
- Main blood antibody of late primary and early secondary responses; passed from carrier to unborn child via placenta.
- IgM:
- Antibody whose monomer is a surface receptor of naive B cells; the pentamer is the first antibody made during primary responses.
- immune system:
- Series of barriers, cells, and soluble mediators that combine in response to infections of the body by pathogenic organisms.
- immunoglobulin (Ig):
- Protein antibody; occurs as one of five main classes.
- immunological memory:
- Ability of the adaptive immune response to mount a stronger and faster immune response upon reexposure to a pathogen.
- inflammation:
- Basic innate immune response characterized by heat, redness, pain, and swelling.
- innate immune response:
- Rapid but relatively nonspecific immune response.
- interferons:
- Early induced proteins made in virally infected cells that cause nearby cells to make antiviral proteins.
- lacteals:
- Lymphatic capillaries in the small intestine critical for the transport of dietary lipids and lipid-soluble vitamins to the blood.
- light chain:
- Small protein chain of an antibody.
- lymph:
- Fluid contained within the lymphatic system.
- lymphatic capillaries:
- Smallest of the lymphatic vessels and the origin of lymph flow.
- lymphatic system:
- Network of lymphatic vessels, lymph nodes, and ducts that carries lymph from the tissues and back to the bloodstream.
- lymphatic trunks:
- Large lymphatics that collect lymph from smaller lymphatic vessels and empty into the blood via lymphatic ducts.
- lymphatic vessels:
- Vessels for transporting the cells of the immune system.
- lymph node:
- One of the bean-shaped organs associated with the lymphatic vessels.
- lymphocytes:
- White blood cells characterized by a large nucleus and small rim of cytoplasm.
- lymphoid follicles:
- The sites of the formation of lymphocytes, with specific B cell–rich and T cell–rich areas.
- lymphoid nodules:
- Unencapsulated patches of lymphoid tissue found throughout the body.
- macrophage:
- Amoeboid phagocyte found in several tissues throughout the body.
- major histocompatibility complex (MHC):
- Gene cluster whose proteins present antigens to T cells.
- mast cell:
- Cell found in the skin and the lining of body cells that contains cytoplasmic granules with vasoactive mediators such as histamine.
- memory T cells:
- Long-lived immune cell reserved for future exposure to a pathogen.
- monocyte:
- Precursor to macrophages and dendritic cells seen in the blood.
- mucosa-associated lymphoid tissue (MALT):
- Lymphoid nodule associated with the mucosa.
- naive lymphocyte:
- Mature B or T cell that has not yet encountered antigen for the first time.
- natural killer (NK) cell:
- Cytotoxic lymphocyte of innate immune response.
- neutrophil:
- Phagocytic white blood cell recruited from the bloodstream to the site of infection via the bloodstream.
- opsonization:
- Enhancement of phagocytosis by the binding of antibody or antimicrobial protein.
- passive immunity:
- Transfer of immunity to a pathogen to an individual that lacks immunity to this pathogen, usually by the injection of antibodies.
- perforin:
- Molecule in NK cell and cytotoxic T cell granules that forms pores in the membrane of a target cell.
- peripheral tolerance:
- Mature B cell made tolerant by lack of T cell help.
- Peyer’s patches:
- A type of MALT in the small intestine important for immune responses against ingested substances.
- phagocytosis:
- Movement of material from the outside to the inside of the cells via vesicles made from invaginations of the plasma membrane.
- plasma cell:
- Differentiated B cell that is actively secreting antibody.
- polyclonal response:
- Response by multiple clones to a complex antigen with many determinants.
- primary adaptive response:
- Immune system’s response to the first exposure to a pathogen.
- primary lymphoid organ:
- Site where lymphocytes mature and proliferate; red bone marrow and thymus gland.
- red pulp:
- Splenic nodule area consisting of mostly red blood cells.
- regulatory T cells (Treg; also suppressor T cells):
- Class of CD4 T cells that regulates other T cell responses.
- right lymphatic duct:
- Drains lymph fluid from the upper right side of the body into the right subclavian vein.
- secondary adaptive response:
- Immune response observed upon reexposure to a pathogen, which is stronger and faster than a primary response.
- secondary lymphoid organs:
- Sites where lymphocytes mount adaptive immune responses; examples include lymph nodes and spleen.
- spleen:
- Secondary lymphoid organ that filters pathogens from the blood (white pulp) and removes degenerating or damaged blood cells (red pulp).
- T cell:
- Lymphocyte that acts by secreting molecules that regulate the immune system or by causing the destruction of foreign cells, viruses, and cancer cells.
- T cell–dependent antigen:
- Antigen that binds to B cells, which requires signals from T cells to make antibody.
- T cell–independent antigen:
- Binds to B cells, which do not require signals from T cells to make antibody.
- Th1 cells:
- Cells that secrete cytokines that enhance the activity of macrophages and other cells.
- Th2 cells:
- Cells that secrete cytokines that induce B cells to differentiate into antibody-secreting plasma cells.
- thoracic duct:
- Large duct that drains lymph from the lower limbs, left thorax, left upper limb, and the left side of the head.
- thymocyte:
- Immature T cell found in the thymus.
- thymus:
- Primary lymphoid organ; where T lymphocytes proliferate and mature.
- tonsils (palatine, pharyngeal, and lingual):
- Lymphoid nodules associated with the nasopharynx.
- white pulp:
- Splenic nodule area that resembles the lymphoid follicles of the lymph nodes.
Chapter Review
20.1 Anatomy of the Lymphatic and Immune Systems
The lymphatic system is a series of vessels, ducts, and trunks that removes interstitial fluid from the tissues and returns it to the blood. The lymphatics are also used to transport dietary lipids and cells of the immune system. Cells of the immune system all come from the hematopoietic system of the bone marrow. Primary lymphoid organs, the bone marrow and thymus gland, are the locations where lymphocytes of the adaptive immune system proliferate and mature. Secondary lymphoid organs are sites in which mature lymphocytes congregate to mount immune responses. Many immune system cells travel through the lymphatic and circulatory systems to patrol the body, destroy abnormal or infected cells, and protect against pathogens.
20.2 Barrier Defences and the Innate Immune Response
Innate immune responses are critical to the early control of infections. Whereas barrier defences are the body’s first line of physical defence against pathogens, innate immune responses are the first line of physiological defence. Innate responses occur rapidly but with less specificity and effectiveness than the adaptive immune response. Innate responses can be caused by a variety of cells, mediators, and antibacterial proteins such as the complement system, a group of plasma proteins that work together to destroy pathogens, enhance phagocytosis, and promote inflammation. Within the first few days of an infection, another series of antibacterial proteins are induced, each with activities against certain bacteria, including opsonization of certain species. Additionally, interferons are induced that protect cells from viruses in their vicinity. Finally, the innate immune response does not stop when the adaptive immune response is developed. In fact, both can cooperate, and one can influence the other in their responses against pathogens.
20.3 The Adaptive Immune Response: T Lymphocytes and Their Functional Types
T cells recognize antigens with their antigen receptor, a complex of two protein chains on their surface. They do not recognize self-antigens, however, but only processed antigen presented on their surfaces in a binding groove of a major histocompatibility complex molecule. T cells develop in the thymus, where they learn to use self-MHC molecules to recognize only foreign antigens, thus making them tolerant to self-antigens. There are several functional types of T lymphocytes, the major ones being helper, regulatory, and cytotoxic T cells.
20.4 The Adaptive Immune Response: B Lymphocytes and Antibodies
B cells, which develop within the bone marrow, are responsible for making five different classes of antibodies, each with its own functions. B cells have their own mechanisms for tolerance, but in peripheral tolerance, the B cells that leave the bone marrow remain inactive due to T cell tolerance. Some B cells do not need T cell cytokines to make antibody, and they bypass this need by the crosslinking of their surface immunoglobulin by repeated carbohydrate residues found in the cell walls of many bacterial species.
Others require T cells to become activated.